SQZ Biotech to Participate in April Investor Events

Rhea-AI Summary

SQZ Biotechnologies (NYSE:SQZ) announced its participation in key investor conferences in April 2021. CEO Armon Sharei, PhD, will present at the 20th Annual Needham Virtual Healthcare Conference on April 13, 2021, at 3:45pm EDT, and join a cell therapy panel at the Canaccord Horizons in Oncology Virtual Conference on April 15, 2021, at 1:00pm EDT. The company will also conduct one-on-one meetings during both events. More details and a webcast of the Needham presentation will be available for 90 days on the SQZ website.

SQZ Biotechnologies (NYSE:SQZ), a cell therapy company developing novel treatments for multiple therapeutic areas, today announced that management will be participating in multiple investor conferences in April 2021. Armon Sharei, PhD, chief executive officer, will present a corporate overview at the 20^th Annual Needham Virtual Healthcare Conference taking place April 12-15, 2021 and will participate in a cell therapy focused panel at the Canaccord Horizons in Oncology Virtual Conference on April 15, 2021. The company will also be hosting one on one meetings at both conferences.

Needham Virtual Healthcare Conference
Presentation: Tuesday, April 13, 2021, 3:45pm EDT

Canaccord Horizons in Oncology Virtual Conference
Panel: Thursday, April 15, 2021, 1:00pm EDT

More information and the webcast for the presentation at Needham will be available on the Investors & Media section of the SQZ website. The webcast will be available for 90 days following the presentation.

About SQZ Biotechnologies

SQZ Biotechnologies is a clinical-stage biotechnology company developing transformative cell therapies for patients with cancer, infectious diseases, and other serious conditions. Using its proprietary technology, SQZ Biotechnologies offers the unique ability to deliver multiple materials into many patient cell types to engineer what we believe can be an unprecedented range of potential therapeutics for a variety of diseases. SQZ Biotechnologies has the potential to create well-tolerated cell therapies that can provide therapeutic benefit for patients and to improve the patient experience over existing cell therapy approaches. With accelerated production timelines under 24 hours and the opportunity to eliminate preconditioning and lengthy hospital stays, our goal is to use the SQZ approach to establish a new paradigm for cell therapies. Our first therapeutic applications aim to leverage the potential to generate target-specific immune responses, both in activation for the treatment of solid tumors and immune tolerance for the treatment of unwanted immune reactions and autoimmune diseases. For more information, please visit www.sqzbiotech.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210406005049/en/

FAQ

What is the date and time of SQZ Biotechnologies' presentation at the Needham Virtual Healthcare Conference?

SQZ Biotechnologies will present on April 13, 2021, at 3:45pm EDT.

When will the Canaccord Horizons in Oncology Virtual Conference panel featuring SQZ Biotechnologies take place?

The panel will occur on April 15, 2021, at 1:00pm EDT.

Where can I find the webcast for the Needham Virtual Healthcare Conference presentation by SQZ Biotechnologies?

The webcast will be available on the Investors & Media section of the SQZ website for 90 days following the presentation.

What is the focus of SQZ Biotechnologies' upcoming conference presentations?

The focus will be on cell therapy advancements and corporate overview.

Is SQZ Biotechnologies hosting one-on-one meetings during the investor conferences?

Yes, SQZ Biotechnologies will host one-on-one meetings at both conferences.